Voxzogo-H-C-PSUSA-00010952-202308: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation
Voxzogo-H-C-PSUSA-00010952-202308: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation
Fortschrittliche pharmazeutische Formulierung für gezielte therapeutische Intervention.
Dosierung
Voxzogo-H-C-PSUSA-00010952-202308: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation
Stärke
Voxzogo-H-C-PSUSA-00010952-202308: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation
Packungsgröße
Voxzogo-H-C-PSUSA-00010952-202308: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation
Form
Voxzogo-H-C-PSUSA-00010952-202308: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation
Quelle
European Medicines Agency
Sicherheitsprofil
Kontraindikationen
Nebenwirkungen
Scanne diesen QR-Code, um schnell auf diese Seite auf deinem Mobilgerät zuzugreifen.